Back to results
US 4,052,383 AGranted
N-diphenylalkyl-2-benzyl azacyclic compounds
AssigneeSchering Corporation
InventorsElijah H. Gold, Daniel M. Solomon
Life of this patent
Estimating the term…
Abstract
Novel N-diphenylalkyl-2-benzyl azacyclic compounds are disclosed which can be used as antiobesity agents. Some of these compounds also exhibit useful antimicrobial properties. Additionally, novel chemical intermediates for the synthesis of this series are provided.
Claims17
A compound of the formula ##STR28## wherein n is an integer from 1 to 5;
- R and R' are independently selected from the group consisting of hydrogen and alkyl of 1-4 carbon atoms;
- X is selected from the group consisting of hydrogen, OR.sub.2 and NR.sub.1 R.sub.3 ;
- R.sub.1 is hydrogen, alkyl of 1-4 carbon atoms, phenyl lower alkyl, ##STR29## and ##STR30## wherein R.sub.4 is alkyl of 1-4 carbon atoms, phenyl, or phenyl lower alkyl.
- R.sub.2 is hydrogen, alkyl of 1-4 carbon atoms, lower alkanoyl, benzoyl or pheyl alkyl of 1-4 carbon atoms;
- R.sub.3 is hydrogen, alkyl of 1-4 carbon atoms and phenyl lower alkyl;
- Y and Y.sub.1 are independently selected from the group consisting of hydrogen, halogen, hydroxy, lower alkoxy and trifluoromethyl;
- Z is a C.sub.1 -C.sub.2 alkylene group, and the pharmaceutically acceptable salts thereof.
4 more elements
Dependencies are inferred from the claim text.